School of Basic Medicine and Forensic Medicine, Henan University of Science & Technology, Luoyang, Henan, People's Republic of China.
Institute of Biomedical Research, Henan Academy of Sciences, Zhengzhou, Henan, People's Republic of China.
Biomed Pharmacother. 2024 Sep;178:117258. doi: 10.1016/j.biopha.2024.117258. Epub 2024 Aug 6.
Carrier-free nanodrugs are a novel type of drug constructed by the self-assembly of drug molecules without carrier involvement. They have the characteristics of small particle size, easy penetration of various barriers, targeting tumors, and efficient release. In recent years, carrier-free nanodrugs have become a hot topic in tumor therapy as they solve the problems of low drug loading, poor biocompatibility, and low uptake efficiency of carrier nanodrugs. A series of recent studies have shown that carrier-free nanodrugs play a vital role in the treatment of various tumors, with similar or better effects than carrier nanodrugs. Based on the literature published in the past decades, this paper first summarizes the recent progress in the assembly modes of carrier-free nanodrugs, then describes common therapeutic modalities of carrier-free nanodrugs in tumor therapy, and finally depicts the existing challenges along with future trends of carrier-free nanodrugs. We hope that this review can guide the design and application of carrier-free nanodrugs in the future.
无载体纳米药物是一种新型药物,由药物分子自组装而成,不涉及载体。它们具有粒径小、易于穿透各种屏障、靶向肿瘤和高效释放等特点。近年来,无载体纳米药物作为解决载体纳米药物载药量低、生物相容性差、摄取效率低等问题的一种新方法,成为肿瘤治疗的热点。一系列最近的研究表明,无载体纳米药物在治疗各种肿瘤方面发挥着重要作用,其效果与载体纳米药物相似或更好。本文基于过去几十年发表的文献,首先总结了无载体纳米药物的组装模式的最新进展,然后描述了无载体纳米药物在肿瘤治疗中的常见治疗方式,最后描述了无载体纳米药物目前存在的挑战和未来的发展趋势。我们希望这篇综述能为无载体纳米药物的设计和应用提供指导。